Anything that is severe, worsening, or systemic is a reason to stop and seek a clinician rather than to adjust the protocol
When Did It Start
(PubMed) Schillace RV, Pisenti N, Pattamanuch N, et al
Its got a more systemic inflammation-fighting, immune-boosting, and healing effect that makes it viable even for the treatment of chronic challenges with unclear sources
Understanding the distinct evidence base, regulatory status, and safety profile of each agent and the complete absence of clinical data on their combined use is essential for patients and healthcare professionals navigating this rapidly evolving and largely unregulated landscape
Studies show that Tesamorelin maintains the natural feedback regulation of the GH axis, with treatment discontinuation resulting in return to baseline GH/IGF-1 levels without evidence of prolonged axis suppression